Home » Topics » Regulatory » EMA

EMA
RSS

Aimovig receives positive CHMP opinion for the prevention of migraine

June 4, 2018

Exondys receives negative CHMP opinion

June 4, 2018

Tegsedi receives positive opinion in Europe

June 4, 2018

EMA validates MAA for Inbrija

May 30, 2018

EMA accepts European filing for edaravone for ALS

May 29, 2018

European designation decisions for BioCryst's BCX-7353 for HAE

May 25, 2018

EMA approves Lynparza tablets for the treatment of platinum-sensitive relapsed ovarian cancer

May 9, 2018

EMA gives positive scientific advice on development plan and regulatory pathway for AM-111

May 8, 2018

EMA validates type II variation application for Opdivo plus Yervoy in first-line NSCLC

May 4, 2018

EMA approves Alpivab for the treatment of influenza

May 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...